Related Articles
Tie2/Tek expression in breast carcinoma: Correlations of immunohistochemical assays and long-term follow-up in a series of 909 patients
Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients
ELAM selectin expression in breast carcinomas detected by automated and quantitative immunohistochemical assays.
Prognostic value of Ki67 and p53 in patients with estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer: Validation of the cut-off value of the Ki67 labeling index as a predictive factor
QUANTITATIVE IMAGING OF PS2 IMMUNOCYTOCHEMICAL ASSAYS IN BREAST CARCINOMAS